JAZZ Jazz Pharmaceuticals plc
Price Chart
Executive Summary
Bruce C. Cozadd, Chairman and CEO of Jazz Pharmaceuticals, filed a Form 144 on June 1, 2026, indicating intent to sell 6,000 shares of common stock. At the filing date, the proposed sale value was approximately $1.41 million, representing a modest portion of his likely total holdings. The filing is a routine insider sale notice and does not signal material concern given the CEO's ongoing role and the relatively small size relative to market cap.
Actionable Insight
This is a routine insider sale notice from the CEO. The 6,000-share amount is small relative to his likely holdings and the company's market cap. No immediate trading action warranted; monitor for any subsequent Form 4 filings to confirm execution and for any pattern of larger sales.
Key Facts
- Filer: Bruce C. Cozadd, Chairman and CEO of Jazz Pharmaceuticals
- Proposed sale: 6,000 shares of common stock
- Estimated value at filing: ~$1,410,720 (based on $235.12/share)
- Shares to be sold from stock options exercised on 03/05/2022
- Broker: Merrill Lynch
- Filing date: June 1, 2026; proposed sale date same day
- Recent insider activity (30d): 4 sells totaling $3.1M
Financial Impact
Proposed sale of 6,000 shares valued at ~$1.41M, representing approximately 0.01% of Jazz's $14.8B market cap
Risk Factors
- CEO selling could be misinterpreted as lack of confidence, though the small size mitigates this
- If this is part of a 10b5-1 plan, the signal is further neutralized
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-039499 |
| Document: 0001628280-26-039499-index.html | 0001628280-26-039499 |
| Document: 0001628280-26-039499.txt | 0001628280-26-039499 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
8d ago
|
DEFA14A
| $229.19 $230.59 | ▲ +0.61% | ▼ −1.80% | $226.88 (−1.01%) |
|
Jun 3, 2026
13d ago
|
Insider Cluster
| $239.17 $236.17 | ▲ +1.26% | ▼ −1.30% | $226.88 (+5.14%) |
|
Jun 3, 2026
13d ago
|
Insider Cluster
| $240.06 $236.17 | ▼ −1.62% | ▲ +0.93% | $226.88 (−5.49%) |
|
Jun 1, 2026
15d ago
|
144
| $226.12 $229.19 | ▲ +1.36% | ▲ +4.32% | $226.88 (+0.34%) |
|
May 29, 2026
18d ago
|
8-K
| $231.19 $238.57 | ▲ +3.19% | ▲ +5.94% | $226.88 (−1.87%) |
|
May 1, 2026
6w ago
|
144
| $202.51 $225.49 | ▲ +11.35% | ▲ +9.00% | $226.88 (+12.03%) |
|
Apr 24, 2026
7w ago
|
10-K/A
| $200.31 $207.89 | ▲ +3.78% | ▲ +3.38% | $226.88 (+13.26%) |
|
Apr 1, 2026
10w ago
|
144
| $186.73 $193.27 | ▲ +3.50% | ▼ −0.12% | $226.88 (+21.50%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $189.00 $181.23 | ▼ −4.11% | ▼ −2.13% | $226.88 (+20.04%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $189.00 $181.23 | ▼ −4.11% | ▼ −2.13% | $226.88 (+20.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access